Bioventus introduced OSTEOMATRIX+® next-generation biphasic bone graft for orthopaedic and spine applications.
OSTEOMATRIX+ combines collagen and hydroxyapatite/beta-tricalcium phosphate granules designed to create a porous scaffold. Updates from the predecessor product include improved moldability, flexibility and versatility.
Bioventus intends to launch several next-gen products within the next five years.
Source: Bioventus
Bioventus introduced OSTEOMATRIX+® next-generation biphasic bone graft for orthopaedic and spine applications.
OSTEOMATRIX+ combines collagen and hydroxyapatite/beta-tricalcium phosphate granules designed to create a porous scaffold. Updates from the predecessor product...
Bioventus introduced OSTEOMATRIX+® next-generation biphasic bone graft for orthopaedic and spine applications.
OSTEOMATRIX+ combines collagen and hydroxyapatite/beta-tricalcium phosphate granules designed to create a porous scaffold. Updates from the predecessor product include improved moldability, flexibility and versatility.
Bioventus intends to launch several next-gen products within the next five years.
Source: Bioventus
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.